No Data
Sector Update: Health Care Stocks Softer in Late Afternoon Trading
Sector Update: Health Care
Theratechnologies Has Submitted A Prior Approval Supplement To The U.S. FDA Describing The Changes Made To The Manufacturing Environment Of The Facility Where EGRIFTA SV Is Produced
Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV Manufacturing Environment
Theratechnologies Brief: Says Received March 2025 PDUFA Goal Date For Updated Tesamorelin F8 Formulation SBLA
Theratechnologies Receives March 2025 PDUFA Goal Date for Updated Tesamorelin F8 Formulation SBLA
No Data